Clinical Trial Update: Probiotic Bacteria in Prevention of the Metabolic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating probiotic bacteria for the prevention of metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Probiotic bacteria preparation

Snippet

Sponsor: University Maribor | Conditions: Metabolic Syndrome X | Phase 2 | Status: COMPLETED